Home > Drug Search >
  • company_query: Apogenix
  •   > 
Drug Filter
Category:
chemistry (3) biology (36)
Status:
Approved (1) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (23) Phase Ⅰ (11)
Clinical Stage:
Pending (5) Active (32) Discontinued (1)
Bio-Type:
Vaccine (8) Recombinant cytokines (8) Recombinant hormone (1) Whole antibody (7) Fab fragment (1) Fusion protein (6)
Indication:
Acute myeloid Leukemia (AML) (1) Allergic conjunctivitis (1) Anemia (3) Asthma (1) Atopic dermatitis (1) Basal cell carcinoma (BCC) (1) Breast cancer (1) Crohn's disease (1) Diarrhea (1) Rheumatic disorders (1) Common warts (1) Gastric cancer (2) Wet age-related macular degeneration (1) HBV infection (1) HCV infection (3) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Somatotropin deficiency (1) Myelodysplastic syndrome (MDS) (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (2) Non-alcoholic fatty liver disease (NAFLD) (1) Ovarian cancer (1) Overactive bladder (OAB) (1) Postherpetic neuralgia (PHN) (1) Post-polycythemia vera (1) Psoriasis (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (1) Cervical intraepithelial neoplasia (1) Colorectal cancer (1) Cryopyrin-Associated Periodic Syndromes (CAPS) (1) Age-related macular degeneration (AMD) (1) Stroke (1) Diabetes (1) Malaria (1) Type 1 diabetes (1) Neutropenia (5) Renal carcinoma (1) Glioblastoma (1) Graft versus host disease (1) Respiratory syncytial virus infection (1) Bullous pemphigoid (1) Central nervous system disorders (1) Ebola virus disease (EVD) (2) Sciatica (1) Inflammation (2) Cervical dysplasia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top